Pharmaceutical Analytical Testing Outsourcing Market:Global Industry Analysis and Forecast (2022-2029)


Pharmaceutical Analytical Testing Outsourcing Market size was valued at US$ 7.66 Bn in 2021 and the total revenue is expected to grow at 8.3% through 2021 to 2029, reaching nearly US$ 14.51 Bn.

Pharmaceutical Analytical Testing Outsourcing Market Overview:

Quality is at the top of pharma's expectations from an analytical testing supplier. Analytical testing labs found in US were around 100 and are employing top-tier scientists and sophisticated equipment to solve business demands, from virtual firms to Big Pharma, whether it's method validation, microbiological testing, tech transfer, or method development.Global Pharmaceutical Analytical Testing Outsourcing MarketTo know about the Research Methodology :- Request Free Sample Report

Pharmaceutical Analytical Testing Outsourcing Market Dynamics:

The market is being driven by innovation in the pharmaceutical business, an increased focus on regulation, safety and quality, an increase in the number of end-users, and the cost savings of outsourcing. Pharmaceutical businesses must increase their R&D spending and invest in drug discovery as part of their long-term sustainability goals. Not every company has the infrastructure to support various types of analytical testing. Since a result, outsourcing these processes is the best alternative, as it saves time and money.

Other factors such as the growing need for Service safety and quality, as well as changing laws for in vivo and in vitro tests, are likely to drive the market forward. For example, China's government issued a notice to improve generic medication quality, clear the backlog of drug Services, improve the quality and transparency of the review and approval process, and support innovative drug R&D at pace with global development.

Market expansion is expected to be aided by the cost savings associated with outsourcing these services and approvals in the pharmaceutical industry. Market growth is aided by faster and more trustworthy findings, data security, and increased efficiency. The need for testing services is directly proportional to innovation or new Service development. Companies are seeking to outsource testing services because of competitive constraints, pricing concerns, and lead-time to market. The entire development pipeline expanded to 16,179 molecules in 2021 from 15,357 molecules in 2018, according to the Pharma Intelligence Report 2021.

Many firms compete in the market, specializing in specialist services or providing end-to-end services. Large outsourcing organizations, on the other hand, are looking to buy high-impact service/manufacturing enterprises to supplement their existing capabilities. Clinical Research Laboratories was acquired by Eurofins in September 2018, and MPI research was acquired by Charles River Laboratories International, Inc., to name a few examples.

Pharmaceutical Analytical Testing Outsourcing Market Segment Analysis:


The other service segment is dominating the Service segment of the Pharmaceutical Analytical Testing Outsourcing Market:

In 2021, the other service segment generated the most revenue, accounting for more than 39% of the total. Environmental monitoring, raw material testing, batch release, microbiological testing, and physical characterization of materials are all part of this sector. Changing legislation for in vivo and in vitro tests, as well as creative ways to reduce test complexity, are driving segment expansion.

Over the projection period, the bioanalytical testing services segment is predicted to develop at the quickest rate. The segment's growth has been aided by the introduction of new players into the market and an increase in the number of clinical trial registrations. Many small-scale firms lack high-end analytical instruments, so they outsource these studies to industry professionals with years of expertise performing, documenting, and reacting to the issues that arise during research. This is also expected to contribute to segment growth.

Pharmaceutical Analytical Testing Outsourcing Market Regional Insights:

North America is estimated to dominate the growth of the Pharmaceutical Analytical Testing Outsourcing Market.

North America held the greatest revenue share of more than 53% in 2020 and will continue to do so throughout the projection period. This is for the reason that it is one of the most important manufacturing centers for complex, highly dependable, and high-end medications. One of the primary reasons expected to drive market expansion is an increase in pharmaceutical manufacturing to fulfill the growing need for effective healthcare in the region. further, companies are focusing on enhancing the testing criteria to boost the preciseness of the end product and to offer high-quality medication. Hence, this factor is estimated to motivate the growth of the regional market in the forecast period.

The Asia Pacific is predicted to be the fastest-growing regional market, as several developed countries invest in the region. Delivery centers in the Philippines, China, and India typically support outsourcing services in APAC. China is becoming more attractive as a delivery site for Japanese nearshore and onshore clients. Further, expansion of the pharmaceutical industry in the region and investment in the healthcare sector by APAC nationals is anticipated to flourish the growth of the market in the forecast time frame. The objective of the report is to present a comprehensive analysis of the Pharmaceutical Analytical Testing Outsourcing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Pharmaceutical Analytical Testing Outsourcing Market dynamics, structure by analyzing the market segments and project the Pharmaceutical Analytical Testing Outsourcing Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Pharmaceutical Analytical Testing Outsourcing Market make the report investor’s guide.

Pharmaceutical Analytical Testing Outsourcing Market Scope: Inquire before buying






Global Pharmaceutical Analytical Testing Outsourcing Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 7.66 Bn.




Forecast Period 2022 to 2029 CAGR:
8.3%
Market Size in 2029:
US $ 14.51 Bn.




 Segments Covered:
by Product
• Bioanalytical
o Clinical
o Non-clinical
• Method Development & Validation
o Extractable & Leachable
o Impurity Method
o Technical Consulting
o Others
• Stability Testing
o Drug Substance
o Stability Indicating Method Validation
o Accelerated Stability Testing
o Photostability Testing
o Others
• Others






Pharmaceutical Analytical Testing Outsourcing Market, by Region

• North America
o US
o Canada
o Mexico
• Europe
o U.K
o France
o Germany
o Italy
o Spain
o Sweden
o CIS Countries
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o ASEAN
o Rest of Asia Pacific
• The Middle East and Africa
o South Africa
o GCC Countries
o Egypt
o Nigeria
o Rest of ME&A
• South America
o Brazil
o Argentina
o Rest of South America

Pharmaceutical Analytical Testing Outsourcing Market Key Players are:

• SGS SA
• Toxikon, Inc.
• Eurofins Scientific
• Pace Analytical Services, Inc.
• Intertek Group Plc
• Pharmaceutical Product Development, LLC.
• WuXi AppTec, Inc.
• Boston Analytical
• Charles River Laboratories International, Inc.
• West Pharmaceutical Services Inc.
• Charles River
• West Pharmaceutical Services Inc.
• Exova
• Source BioScienc
• Ajinomoto Bio-Pharma
• Catalent, Inc
• Gateway Analytical
• Alcami Corporation
• Aztech Sciences Inc.
• Recro and AptarGroup, Inc.

FAQs:

1. What is the Pharmaceutical Analytical Testing Outsourcing market value in 2021?
Ans: Pharmaceutical Analytical Testing Outsourcing market value in 2021 was estimated as 7.66 Billion USD.

2. What is the Pharmaceutical Analytical Testing Outsourcing market growth?
Ans: The Pharmaceutical Analytical Testing Outsourcing market is anticipated to grow with a CAGR of 8.3% in the forecast period and is likely to reach USD 14.51 Billion by the end of 2029.

3. Which Service segment is expected to dominate the Pharmaceutical Analytical Testing Outsourcing market during the forecast period?
Ans: The other services segment, comprising of environmental monitoring, raw material testing, batch release, microbial testing, and physical characterization of the materials, accounted for the largest share of over 39% in the pharmaceutical analytical testing outsourcing market in 2021.

4. Who are the key players in the Pharmaceutical Analytical Testing Outsourcing market?
Ans: Some key players operating in the pharmaceutical analytical testing outsourcing market include Toxikon, Inc.; Intertek Group PLC; SGS SA; Eurofins Scientific; Boston Analytical; Pace Analytical Services, LLC; West Pharmaceutical Services, Inc.; WuXi AppTec, Inc.; Intertek Group Plc; Pharmaceutical Product Development, LLC; and Charles River Laboratories International, Inc.

5. What is the key driving factor for the growth of the Pharmaceutical Analytical Testing Outsourcing market?
Ans: Key factors that are driving the pharmaceutical analytical testing outsourcing market growth include increasing demand for analytical drugs, biosimilars, and biopharmaceuticals as well as increasing investments in R&D for pharmaceuticals, rising demand for product safety, and quality, and changing regulations for in-vivo and in-vitro tests. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Pharmaceutical Analytical Testing Outsourcing Market Size, by Market Value (US$ Bn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2020
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Pharmaceutical Analytical Testing Outsourcing Market
3.4. Geographical Snapshot of the Pharmaceutical Analytical Testing Outsourcing Market, By Manufacturer share
4. Pharmaceutical Analytical Testing Outsourcing Market Overview, 2021-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porter Five Forces Analysis
4.1.6.1. The threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. The threat of Substitute Grades
4.1.6.5. The intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Pharmaceutical Analytical Testing Outsourcing Market
5. Supply Side and Demand Side Indicators
6. Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecast, 2021-2029
6.1. Pharmaceutical Analytical Testing Outsourcing Market Size & Y-o-Y Growth Analysis.
7. Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
7.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
7.1.1. Bioanalytical
7.1.1.1. Clinical
7.1.1.2. Non-clinical
7.1.2. Method Development & Validation
7.1.2.1. Extractable & Leachable
7.1.2.2. Impurity Method
7.1.2.3. Technical Consulting
7.1.2.4. Others
7.1.3. Stability Testing
7.1.3.1. Drug Substance
7.1.3.2. Stability Indicating Method Validation
7.1.3.3. Accelerated Stability Testing
7.1.3.4. Photostability Testing
7.1.3.5. Others
7.1.4. Others
8. Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
9.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
9.1.1. Bioanalytical
9.1.1.1. Clinical
9.1.1.2. Non-clinical
9.1.2. Method Development & Validation
9.1.2.1. Extractable & Leachable
9.1.2.2. Impurity Method
9.1.2.3. Technical Consulting
9.1.2.4. Others
9.1.3. Stability Testing
9.1.3.1. Drug Substance
9.1.3.2. Stability Indicating Method Validation
9.1.3.3. Accelerated Stability Testing
9.1.3.4. Photostability Testing
9.1.3.5. Others
9.1.4. Others
10. North America Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
11.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
12. Canada Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
12.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
13. Mexico Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
13.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
14. Europe Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
14.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
15. Europe Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
16.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
17. France Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
17.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
18. Germany Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
18.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
19. Italy Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
19.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
20. Spain Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
20.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
21. Sweden Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
21.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
22. CIS Countries Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
22.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
23. Rest of Europe Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
23.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
24. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
24.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
25. Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
26.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
27. India Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
27.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
28. Japan Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
28.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
29. South Korea Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
29.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
30. Australia Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
30.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
31. ASEAN Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
31.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
32. Rest of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
32.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
33. Middle East Africa Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
33.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
34. Middle East Africa Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
35.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
36. GCC Countries Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
36.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2021-2029
37.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
38. Nigeria Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
38.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
39. Rest of ME&A Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
39.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
40. South America Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
40.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
41. South America Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
42.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
43. Argentina Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
43.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
44. Rest of South America Pharmaceutical Analytical Testing Outsourcing Market Analysis and Forecasts, 2021-2029
44.1. Market Size (Value) Estimates & Forecast By Service, 2021-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Pharmaceutical Analytical Testing Outsourcing Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment
45.2.2. New Grade Launches and Grade Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment, and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements
45.3. Company Profile: Key Players
45.3.1. Novartis AG
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Grade Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Development
45.3.2. SGS SA
45.3.3. Toxikon, Inc.
45.3.4. Eurofins Scientific
45.3.5. Pace Analytical Services, Inc.
45.3.6. Intertek Group Plc
45.3.7. Pharmaceutical Product Development, LLC.
45.3.8. WuXi AppTec, Inc.
45.3.9. Boston Analytical
45.3.10. Charles River Laboratories International, Inc.
45.3.11. West Pharmaceutical Services Inc.
45.3.12. Charles River
45.3.13. West Pharmaceutical Services Inc.
45.3.14. Exova
45.3.15. Source BioScienc
45.3.16. Ajinomoto Bio-Pharma
45.3.17. Catalent, Inc
45.3.18. Gateway Analytical
45.3.19. Alcami Corporation
45.3.20. Aztech Sciences Inc.
45.3.21. Recro and AptarGroup, Inc.
46. Primary Key Insights
  • INQUIRE BEFORE BUYING